NCT00001382View on ClinicalTrials.gov

A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate

PHASE1CompletedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

March 31, 1994

Study Completion Date

March 31, 2000

Conditions

Prostatic Neoplasms

Interventions

BIOLOGICAL

PROSTVAC

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH